Current trends in antimalarial chemotherapy

Drugs of the Future

Volumn 28, Issue 3, 2003, Pages 243-255

  Kumar, Arun ^a   Katiyar, Sanjay Babu ^a   Agarwal, Anu ^a   Chauhan, Prem M S ^a,b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 [4 (3 ACETYL 4,5 DIHYDRO 2 FURYLAMINO) 1 METHYLBUTYLAMINO] 6 METHOXYQUINOLINE; ACRIDINE DERIVATIVE; AMIDINE; AMODIAQUINE; AMOPYROQUINE; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ATOVAQUONE; BISACRIDINE DERIVATIVE; BISQUINOLINE; CARBOLINE DERIVATIVE; CHLOROQUINE; CYCLOGUANIL; IMIDAZOLE; ISOQUINOLINE; MEFLOQUINE; N [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] N' ISOPROPYLIMIDOCARBONIMIDIC DIAMIDE; NATURAL PRODUCT; PEROXIDE; PHENYL BETA METHOXY ACRYLATE; PRIMAQUINE; PROGUANIL; PYRIMIDINE; PYRROLIDINE DERIVATIVE; QUINOLINE; SESQUITERPENE LACTONE; SULFONAMIDE; SULFONE; TAFENOQUINE; TETRAOXONE DERIVATIVE; TRIOXANE; TROPOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; MALARIA; NONHUMAN; PLASMODIUM; REVIEW;

EID: 0037678679     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2003.028.03.720299     Document Type: Review

References (70)

1. Chauhan, P.M.S., Srivastava, S.K. Present trends and future strategy in chemotherapy in malaria. Curr Med Chem 2001, 8: 1535-42.
2. Warhurst, D.C. Antimalarial drug discovery: Development of inhibitors of dihydrofolate reductase active in drug resistance. DDT 1998, 13: 538-46.
3. Sanchez-Delgado, R.A., Navarro, M., Perez, H., Urbina, J.A. Toward a novel metal-based chemotherapy against tropical disease 2: Synthesis and antimalarial activity in vitro and in vivo of new ruthenium and rhodium chloroquine complexes. J Med Chem 1996, 39: 1095-9.
4. Etlinger, H.M., Felix, A.M., Gillessen, D. et al. Assesement in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. J Immunology 1981, 40: 626-33.
5. Sweeney, T.R. Drugs with quinine-like action. Handbook Exp Pharmacol 1984, 68: 267-324.
6. Wyler, D.J., Oppenheim, J.J. Lymphocyte transformation in human Plasmodium falciparum malaria. J Immunol 1974, 113: 449-54.
7. Sweeney, T.R. The present status of malaria chemotherapy: Mefloquine a novel antimalarial. Med Res Rev 1981, 1: 281-301.
8. Bruce-Chwatt, L.J., Black, R.H., Canfield, C.J., Clyde, D.F., Peters W., Wernsdorfer, W.H. (Eds.). Chemotherapy of Malaria, 2nd Edition. WHO: Geneva 1986.
9. Sharma, S. Vector borne diseases. Prog Drug Res 1990, 35: 365-485.
10. Bell, A. Recent development in the chemotherapy of malaria. Curr Opin Anti-infective Invest Drugs 2000, 2: 63-70.
11. Chauhan, P.M.S. PS-15 Jacobus Pharm Co. Inc. Curr Opin Anti-infective Invest Drugs 2000, 2: 103-8.
12. Singh, C., Puri, S.K. Indian Patent Application 1583/DEL/99 dt.28.12.99.
13. O'Neill, P.M., Searle, L. et al. Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether. J Med Chem 1999, 42: 5487-93.
14. Li, Y., Zhu, Y.M., Jiang, H.J. et al. Synthesis and antimalarial activity of artemisinin derivatives containing an amino group. J Med Chem 2000, 43: 1635-40.
15. Mekonnen, B., Weiss, E., Katz, E. et al. Synthesis and antimalarial activities of base catalysed adducts of 11-azaartemisinin. Bioorg Med Chem 2000, 8: 1111-6.
16. Posner, G.H., Maxwell, J.P., O'Dowd, H. et al. Antimalarial sulfide, sulfone, and sulfonamide trioxanes. Bioorg Med Chem 2000, 8: 1361-70.
17. Delhaes, L., Blot, C., Berry, L. et al. Novel ferrocenic artemisinin derivatives: Synthesis, in vitro antimalarial activity and affinity of bibding with ferroprotoporphyrin. Bioorg Med Chem 2000, 8: 2739-45.
18. O'Niell, P.M., Miller, A., Bishop, L.P. et al. Synthesis, antimalarial activity, biomimetic of iron(II) chemistry, and in vivo metabolism of novel, potent C-10 phenoxy derivatives of dihydroartemisinin. J Med Chem 2001, 44: 58-68.
19. Posner, G.H., Heung, J.P., Jeon, B. et al. Antimalarial simplified 3-aryltrioxanes: Synthesis and preclinical efficacy/toxicity testing in rodents. J Med Chem 2001, 44: 3054-8.
20. Hindley, S., Ward, C.A., Storr, R.C. et al. Mechanism-based design of parasite-targeted artemisinin derivatives: Synthesis and antimalarial activity of new diamine containing analogues. J Med Chem 2002, 45: 1052-63.
21. Posner, G.H., Northrop, J., Paik, I.H. et al. New chemical and biological aspects of artemisinin-derived trioxan dimers. Bioorg Med Chem 2002, 10: 227-32.
22. McCullough, K.J., Wood, J.K., Bhattacharjee, A.K. et al. Methyl-substituted dispiro-12,4,5-tetraoxanes: Correlations of structural studies with antimalarial activity. J Med Chem 2000, 43: 1246-9.
23. Opsenica, D., Pocsfalvi, G., Juranic, Z. et al. Cholic acid derivatives as 1,2,4,5-tetraoxane carriers: Structure and antimalarial and antiproliferative activity. J Med Chem 2000, 43: 3274-82.
24. Kim, H.S., Nagai, Y., Ono, K. et al. Synthesis and antimalarial activity of novel medium sized 1,2,4,5-tetraoxacycloalkanes. J Med Chem 2001, 44: 2357-61.
25. Sundar, N., Jacob, V.T., Valecha, N., Bigwas, S. Antimalarial t-butylperoxyamines. Bioorg Med Chem Lett 2001, 11: 2269-72.
26. Hamada, Y., Tokuhara, H., Masuyama, A. et al. Synthesis and notable antimalarial activity of acyclic peroxides, 1-(alkyldioxy)-1-(methyldioxy)cyclododecanes. J Med Chem 2002, 45: 1374-8.
27. Murakami, N., Kawanishi, M., Itagaki, S., Horii, T., Kobayashi, M. New readily accessible peroxides with high antimalarial potency. Bioorg Med Chem Lett 2002, 12: 69-72.
28. Delarue, S., Girault, S. Maes, L. et al. Synthesis and in vitro and in vivo antimalarial activity of new 4-aminoquinolines. J Med Chem 2001, 44: 2827-33.
29. Vennerstrom, J.L., Ellis, W.Y., Agar, A.L. Jr. et al. Bisquinolines 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria. J Med Chem 1992, 35: 2129-34.
30. Raynes, K., Galatis, D., Cowman, A.F., Tilley, L., Deady, L.W. Synthesis and activity of some antimalarial bisquinolines. J Med Chem 1995, 38: 204-6.
31. Vennerstrom, J.L., Ager, A.L., Dorn, A. et al. Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines. J Med Chem 1998, 41: 4360-4.
32. Girault, S., Grellier, P., Berecibar, A. et al. Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with linear or cyclic amino linkers. J Med Chem 2001, 44: 1658-65.
33. Ayad, F., Tilley, L., Deady, L.W. Synthesis, antimalarial activity and inhibition of haem detoxification of novel bisquinolines. Bioorg Med Chem Lett 2001, 11: 2075-7.
34. Xiao, Z., Waters, N.C., Woodard, C.L., Li, Z., Li, P.K. Design and synthesis of Pfmrk inhibitors as potential antimalarial agents. Bioorg Med Chem Lett 2001, 11: 2875-8.
35. Iwasa, K., Moriyasu, M., Tachibana, Y. et al. Simple isoquinoline and benzylisoquinoline alkaloids as potential antimicrobial, cytotoxic and anti-HIV agents. Bioorg Med Chem 2001, 9: 2871-84.
36. Rastelli, G., Sirawaraporn, W., Sompompisut, P. et al. Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: Structural basis of antifolate resistance. Bioorg Med Chem 2000, 8: 1117-28.
37. Tarnchompoo, B., Sirichaiwat, C., Phupong, W. et al. Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+s108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum. J Med Chem 2002, 45: 1244-52.
38. Chibale, K., Haupt, H., Kendrick, H. et al. Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine. Bioorg Med Chem Lett 2001, 11: 2655-7.
39. Girault, S., Grellier, P., Berecibar, A. et al. Antimalarial antitrypanosomal and antileishmanial activities and cytotoxicity of bis(9-amino-6-chloro-2-methoxyacridines): Influence of the linker. J Med Chem 2000, 43: 2646-54.
40. Wiesner, J., Wibner, P. Dahse, H. et al. Discovery of a novel lead structure for antimalarials. Bioorg Med Chem 2001, 9: 785-92.
41. Wiesner, J., Mitsch, A., Wibner, P. et al. Structure-activity relationship of novel antimalarial agents. Part 2: Cinnamic acid derivatives. Bioorg Med Chem Lett 2001, 11: 423-4.
42. Wiesner, J., Kettler, K., Jomma, H. et al. Structure-activity relationships of novel antimalarial agents. Part 3: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amides. Bioorg Med Chem Lett 2002, 12: 543-5.
43. Colletti, S.L., Myres, R.W., Darkin-Rattray, S.J. et al. Broad spectrum antiprotozoal agents that inhibit histone deacetylase: Structure-activity relationships of apicidin. Part 1. Bioorg Med Chem Lett 2001, 11: 107-11.
44. Colletti, S.L., Myres, R.W., Darkin-Rattray, S.J. et al. Broad spectrum antiprotozoal agents that inhibit histone deacetylase: Structure-activity relationships of apicidin. Part 2. Bioorg Med Chem Lett 2001, 11: 113-7.
45. Murray, P.J., Kranz, M., Ladlow, M. et al. The synthesis of cyclic tetrapeptoid analogues of the antiprotozoal natural product apicidin. Bioorg Med Chem Lett 2001, 11: 773-6.
46. Alzeer, J., Chollet, J., Heinze-Krauss, I., Hubschwerlen, C., Matile, H., Ridley, R.G. Phenyl β-methoxyacrylates: A new antimalarial pharmacophore. J Med Chem 2000, 43: 560-8.
47. Batra, S., Srivastava, P., Roy, K., Pandey, V.C., Bhaduri, A.P. A new class of potential chloroquine-resistance reversal agents for plasmodia: Syntheses and biological evaluation of 1-3′-diethylaminopropyl)-3-(substituted phenylmethylene) pyrrolidines. J Med Chem 2000, 43: 3428-33.
48. Arzel, E., Rocca, P., Grellier, P. et al. New synthesis of benzo-δ-carbolines, cryptolepines, and their salts: In vitro cytotoxic, antiplasmodial, and antitrypanosomal activities of δ-carbolines, benzo-δ-carbolines, and cryptolepines. J Med Chem 2001, 44: 949-60.
49. Wright, C.W., Addae-Kyereme, J., Breen, A.G. et al. Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. J Med Chem 2001, 44: 3187-94.
50. Ohkanda, J., Lockman, J.W., Yokoyama, K. et al. Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity. Bioorg Med Chem Lett 2001, 11: 761-4.
51. Ren, H., Grady, S., Gamenara, D. et al. Design, synthesis and biological evaluation of a series of simple and novel potential antimalarial compounds. Bioorg Med Chem Lett 2001, 11: 1851-4.
52. Reichenberg, A., Wiesner, J., Weidemeyer, C. et al. Diaryl ester prodrugs of FR00098 with improved in vivo antimalarial activity. Bioorg Med Chem Lett 2001, 11: 833-5.
53. Martin, M.B., Grimley, J.S., Lewis, J.C. et al. Biphosphonates inhibit the growth of Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy. J Med Chem 2001, 44: 909-16.
54. Takasu, K., Inoue, H., Kim, H. et al. Rhodacyanine dyes as antimalarials. 1. Preliminary evaluation of their activity and toxicity. J Med Chem 2002, 45: 995-8.
55. 6-substituted adenosine derivatives. Part 1. Bioorg Med Chem 2002, 10: 769-77.
56. Griffith, R., Chanphen, R., Leach, S.P., Keller, P.A. New antimalarial compounds from database searching. Bioorg Med Chem Lett 2002, 12: 539-42.
57. Calas, M., Ancelin, M.L., Cordina, G. et al. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipids metabolism: Comparison between mono-and bisquaternary. J Med Chem 2000, 43: 505-16.
58. Parfitt, K. (Ed.). Martindale The Complete Drug Reference, 32nd Ed. Pharmaceutical Press: London 1999, 422.
59. Hien, T.T., White, N.J. Qinghaosu. Lancet 1993, 341: 603-8.
60. WHO report of an informal consultation. Geneva, March 14-17, 1994 WHO/MAL/94.1070.
61. Bjokman, A., Phillips-Howard, P.A. The epidemiology of drug-resistant malaria. Trans R Soc Trop Med Hyg 1990, 84: 177-80.
62. Wernsdorfer, W.H. The development and spread of drug resistant malaria. Parasitol Today 1991, 7: 297-302.
63. Brasseur, P., Bitsindou, P., Moyou, R.S. et al. Fast emergence of Plasmodium falciparum resistance to halofantrine. Lancet 1993, 341: 901-2.
64. Brasseur, P., Kouamouo, J., Moyou, R.S., Druilhe, P. Emergence of mefloquine resistant malaria in Africa without drug pressure. Lancet 1990, 336: 59.
65. Brasseur, P., Kouamouo, J., Moyou, R.S., Druilhe, P. Multidrug resistant falciparum malaria in Cameroon in 1987-1988 II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am J Trop Med Hyg 1992, 46: 8-14.
66. Nosten, F., Ter Kuile, F., Chongsuphajaisiddhi, T. et al. Mefloquine resistant falciparum malaria on the Thai-Burmese border Lancet 1991, 337: 1140-3.
67. Fontanet, A.L., Johnston, D.B., Walker, A.M. et al. High prevalence of mefloquine resistant falciparum malaria in eastern Thailand. Bull World Health Organ 1993, 71: 377-83.
68. Basko, L.K. Type RI resistance to halofantrine in West Africa. Trop Med Parasitol 1991, 42: 413-4.
69. Ter Kuile, F.O., Dolan, G., Nosten, G. et al. Halofantrine versus mefloquine in treatment of multidrug-resistant falcipanum malaria. Lancet 1993, 341: 1044-9.
70. Pukrittayakamee, S., Supanaranond, W., Looareesuwan, S., Vanijanonta, S., White, N.J. Quinine in severe falciparum malaria: Evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 1994, 88: 324-7.